Drugs / aQIVc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06015282 | Nov 2023 → Mar 2024 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aQIVc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06015282 ↗ |
| Modality | Vaccine | “Investigational Adjuvanted Cell-derived Quadrivalent Influenza vaccine” NCT06015282 ↗ |